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Abstract
 
Antigen recognition by clonotypic B cell receptor (BcR) is the first step of B lymphocytes
differentiation into plasmocytes. This B cell function is dependent on efficient major histo-
compatibility complex (MHC) class II–restricted presentation of BcR-bound antigens. In this
work, we analyzed the subcellular mechanisms underlying antigen presentation after BcR en-
gagement on B cells. In quiescent B cells, we found that MHC class II molecules mostly accu-
mulated at the cell surface and in an intracellular pool of tubulovesicular structures, whereas
H2-M molecules were mostly detected in distinct lysosomal compartments devoid of MHC
class II. BcR stimulation induced the transient intracellular accumulation of MHC class II mol-
ecules in newly formed multivesicular bodies (MVBs), to which H2-M was recruited. The
reversible downregulation of cathepsin S activity led to the transient accumulation of invariant
chain–MHC class II complexes in MVBs. A few hours after BcR engagement, cathepsin S
activity increased, the p10 invariant chain disappeared, and MHC class II–peptide complexes
arrived at the plasma membrane. Thus, BcR engagement induced the transient formation of
antigen-processing compartments, enabling antigen-specific B cells to become effective antigen-
presenting cells.
Key words: antigen presentation • multivesicular body • lysosome • B lymphocyte • antigen 
receptor
 
Introduction
 
The interaction of antigens with specific B cell antigen re-
ceptors (BcRs)
 
*
 
 initiates the antibody response by induc-
ing the proliferation and differentiation of B cells and the
interaction of B cells with antigen-specific CD4
 
 
 
 T cells.
The expression of clonotypic BcR is an important feature
of B cells because the binding of antigen to this receptor
triggers antigen presentation at very low antigen concen-
trations whereas the fluid phase uptake of similar low con-
centrations of antigen does not (1). The components of
BcR account for the specificity of antigen presentation in
B cells. Surface Ig (sIg) binds antigen, and a noncovalently
associated heterodimer, Ig-
 
 
 
/Ig-
 
 
 
, couples the receptor to
 
cytosolic effectors that trigger the uptake of antigen and a
signaling cascade leading to B cell activation (2). Thus,
BcR facilitates the endocytosis of soluble antigens and
their transport to endosomal/lysosomal compartments
(3). The antigens are then degraded into peptides, which
associate with MHC class II molecules for presentation to
T lymphocytes.
The loading of MHC class II molecules with antigenic
peptides occurs in distinct compartments of the endocytic
pathway, which can be identified based on ultrastructural
morphology and protein content. Historically, MHC class
II compartments (MIICs) were first described in human B
cell lines as multilaminar (late MIICs) or multivesicular
prelysosomal compartments (early MIICs; references 4
and 5) containing lysosomal proteins (
 
 
 
 hexosaminidase,
cathepsin D, lysosomal-associated membrane protein
[Lamp] 1, and CD63). Subcellular fractionation studies
then identified specialized compartments, such as MHC
class II vesicules (CIIV) in A20 mouse B lymphoma cells
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(6). CIIVs are more closely related to endosomes than to
lysosomes because they contain transferrin receptors and
are devoid of lysosomal markers. Recent data have recon-
ciled these observations by showing that the accumulation
of MHC class II in these two different types of processing
compartment is differentially regulated during dendritic
cell (DC) maturation (7). In immature DCs, MHC class II
accumulates in MIICs, together with H2-M and invariant
chain fragments. In LPS-induced mature DCs, mature
MHC class II molecules have been detected on their way
to the cell surface, in CIIV devoid of H2-M and invariant
chain, but rich in costimulatory molecules (7). The low
level of invariant chain fragments in mature DCs was at-
tributed to the upregulation of cathepsin S activity during
DC maturation (8), suggesting that the content of endoly-
sosomal compartments may be regulated by cell activa-
tion.
Recent data have suggested that class II compartments in
B cells may also be modified after BcR engagement (9). In-
deed, antigen-bound BcR are redistributed at the plasma
membrane with lipid microdomains (rafts), which remain
associated with BcR during its transport to antigen-pro-
cessing compartments containing MHC class II molecules
(10). BcR stimulation also modifies the structural features
of MIICs by enlarging class II- and Lamp 1-positive vesi-
cles in B cells (11). Thus, the binding of antigen to BcR
may have a major effect on the membrane microenviron-
ment surrounding BcR in the endocytic pathway and may
change the nature and composition of MHC class II–con-
taining compartments.
These data raise questions about how BcR engagement
leads to efficient MHC class II–restricted antigen presen-
tation in B cells. We addressed this issue using the mouse
B lymphoma cell lines IIA1.6 and A20. Unlike EBV-
transformed human B cells, which are constitutively acti-
vated by viral proteins, these cells have the phenotype of
nonactivated mature B cells, in which MHC class II mol-
ecules mostly accumulate at the cell surface and in a tubu-
lovesicular network of endosomal-like vesicles similar to
CIIV, as previously described in IIA1.6 and A20 B cells
(6, 12).
We found that BCR stimulation induced the downregu-
lation of cathepsin S activity and the intracellular accumu-
lation of class II–invariant chain complexes. MHC class II
molecules were thus redistributed — together with Ii, anti-
gen-bound sIg, and H2-M — to newly formed late endo-
somal multivesicular compartments similar to MIIC. These
dynamic changes in the endocytic MHC class II pathway
were transient and reversible because, 24 h later, MHC
class II were mostly detected in CIIV-like compartments
and cathepsin S activity had returned to its initial level.
Thus, BcR seem to integrate signaling and antigen-target-
ing functions, thereby modulating the composition and na-
ture of the endocytic compartments of B cells. Dynamic
changes in MIICs are therefore a major consequence of
BcR engagement and constitute an original mechanism
leading to the selective and efficient presentation of BcR-
bound antigens.
 
Materials and Methods
 
Cells, Chemical Reagents, and Antibodies.
 
IIA1.6 cells, A20
cells expressing anti-DNP IgM, and 24.4 Hybidoma T cells were
cultured in RPMI 1640, 10% FCS, 1% penicillin-streptomycin,
0.1% 
 
 
 
-mercaptoethanol, and 2% sodium pyruvate. The IIA1.6
B lymphoma cell line is an Fc
 
 
 
R-deficient variant of A20 B cells
(13). G418 (1 mg/ml) was added in the culture medium of A20
cells. A20 IgM anti-DNP cells are A20 B lymphoma cells that
have been transfected with genomic clones encoding the light
chain and the heavy 
 
 
 
 chain specific for the hapten, DNP (14).
24.4 T cells are specific for a 
 
 
 
 repressor peptide (12–24) pre-
sented by IAd MHC class II molecules (15). IIA1.6 cells express-
ing IA
 
 
 
 or IA
 
 
 
 were obtained by transfection of cells with the
corresponding cDNAs encoding the IA 
 
 
 
 and 
 
 
 
 chains (gifts
from R. Germain, National Institutes of Health, Bethesda, MD),
which were inserted into SR-driven expression vectors bearing
neomycin and hygromycin resistance genes, respectively (15).
Cells were cultured with 500 
 
 
 
g/ml hygromycin and 1 mg/ml
G418, in 96-well plates, and positive clones were identified by
cytofluorometry with Y3P or 11.5.2 mAbs specific for the b and
k IA alleles, respectively. RPMI 1640, FCS, PBS, penicillin,
streptomycin, sodium pyruvate, and 
 
L
 
-glutamine were purchased
from GIBCO BRL. All other chemicals used in this study were
obtained from Sigma-Aldrich.
The antibodies used were a rabbit anti-serum specific for the
cytoplasmic domain of the IA 
 
 
 
 chain and a rabbit anti-serum
specific for the cytoplasmic tail of the Ii chain (IiNH2) (a gift
from J. Davoust, Centre D’Immunologie de Marseille Luminy,
Marseille, France). Anti–H2-M antiserum was obtained by im-
munizing rabbits with a synthetic peptide corresponding to the
cytoplasmic tail of the 
 
 
 
 chain. Igs were then obtained by affinity
purification. For immunogold labeling, MHC class II molecules
were detected with the rat anti–class II mAb M5/114 (16). In
some experiments, the M5114 mAb was conjugated to biotin.
The other antibodies used were anti-Lamp1 mAb (BD PharMin-
gen), anti-
 
 
 
 tubulin mAb (Sigma-Aldrich), rabbit anti-biotin an-
tiserum, rabbit anti-fluorescein antiserum (Molecular Probes),
F(ab
 
 
 
)
 
2
 
 fragments of goat anti–mouse IgG anti-serum (Cappel),
and F(ab
 
 
 
)
 
2
 
 fragments of donkey anti–goat IgG antiserum (Jack-
son ImmunoResearch Laboratories). Horseradish peroxidase–
coupled and AP-coupled goat anti–rabbit IgG antiserum were
obtained from Jackson ImmunoResearch Laboratories. Rabbit
anti-cathepsin S antiserum was a gift from H. Chapman, Harvard
University, Boston, MA; rabbit anti-Ig-
 
 
 
 antiserum was a gift
from J. Cambier (National Jewish Hospital, Denver, CO) and rat
anti–H2-M mAb (2C3A) was a gift from L. Karlssonn (La Jolla,
San Diego, CA). The rabbit anti-rab5 and anti-rab7 antisera were
gifts from P. Chavrier (Institut Curie, Paris, France). OVA or 
 
 
 
repressor was coupled to DNP (10 molecules of DNP for 1 mol-
ecule of protein) as described previously (15). 
 
BcR Stimulation of IIA1.6 Cells.
 
IIA1.6 cells and A20 IgM
anti-DNP cells were stimulated with multivalent ligands of BcR.
F(ab
 
 
 
)
 
2
 
 fragments of goat anti–mouse IgG antiserum (10 
 
 
 
g/ml)
and F(ab
 
 
 
)
 
2
 
 fragments of donkey anti–goat IgG antiserum (20 
 
 
 
g/
ml) were mixed in RPMI media and incubated at 37
 
 
 
C for 30
min to facilitate the formation of multivalent anti–mouse IgG
complexes. FACS
 
®
 
 analysis showed that these complexes bound
specifically to the mouse mIgG of IIA1.6 cells or the IgM of A20
cells (data not shown). IIA1.6 cells or A 20 cells were stimulated
by incubation with preformed multivalent ligands at 37
 
 
 
C for 30
min in culture medium and were then washed three times in
PBS. A20 IgM anti-DNP cells were stimulated in similar condi-
tions with 10 
 
 
 
g/ml of DNP-coupled OVA or 
 
 
 
 repressor. The 
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cells were either analyzed directly or subjected to further chase
periods for various lengths of time in complete culture medium.
For electron microscopy, IIA1.6 cells were stimulated with
F(ab
 
 
 
)
 
2
 
 fragments of goat anti–mouse IgG antiserum complexed
with FITC-coupled F(ab
 
 
 
)
 
2
 
 fragments of donkey anti–goat IgG
antiserum, whereas A20 IgM anti-DNP cells were stimulated
with DNP-coupled OVA.
 
Cell Fractionation and Immunoblotting.
 
Cells were fractionated
on Percoll gradients as described previously (17). Briefly, 3 
 
 
 
 10
 
7
 
IIA1.6 cells were washed once with PBS, collected by centrifuga-
tion and resuspended in homogenization buffer (10 mM trietha-
nolamine, 10 mM acetic acid, 1 mM EDTA, and 250 mM su-
crose, pH 7.4) at a density of 3 
 
 
 
 10
 
7
 
 cells per milliliter and
passed through a ball-bearing homogenizer 8–10 times. Intact
cells and nuclei were removed by centrifugation at 3,000 
 
g
 
 for 10
min. The postnuclear supernatant (500 
 
 
 
l) was mixed with ho-
mogenization buffer and Percoll to give 5 ml of a 22% Percoll so-
lution, which was then centrifuged at 33,000 rpm for 30 min in a
Beckman ultracentrifuge, using a TLA-100.4 rotor. Fractions
were collected from the bottom of the gradient. 
 
 
 
-hexosamini-
dase and alkaline phosphodiesterase (APDE) enzymological assays
were performed as described previously (18) to identify the sub-
cellular fractions containing lysosomes and plasma membranes,
respectively. Briefly, 75 
 
 
 
l of each fraction was incubated with
100 
 
 
 
l of the APDE substrate for 1 h at 37
 
 
 
C; a colorimetric assay
was then performed in which absorbance was measured at 405
nm. For the 
 
  
 
hexosaminidase assay, 5 
 
 
 
l of each fraction was in-
cubated for 30 min with 50 
 
 
 
l of the enzyme substrate buffer.
The reaction was stopped by adding 2 ml of stop buffer and the
amount of enzyme was determined by fluorimetry (Hoefer) at an
excitation wavelength of 365 nm and an emission wavelength of
450 nm. The content of each fraction was also determined by
Western blotting with specific anti-rab5, anti-rab7, anti–H2-M,
and anti-Lamp1 antibodies. We quantified MHC class II and in-
variant chain in experiments investigating the redistribution
MHC class II–invariant chain complexes by pooling the fractions
with 
 
  
 
hexosaminidase or APDE activity and subjecting them to
SDS-PAGE. The protein bands were blotted onto membranes,
which were probed with rabbit anti-IA 
 
 
 
 chain or anti–Ii-NH2
antibodies, then with alkaline phosphatase-coupled antisera.
Binding was detected by incubation at room temperature in
buffer containing AP substrate (Boehringer Mannheim). Signals
were detected in a Storm 860 apparatus (Molecular Dynamics)
and quantified with ImageQuant software. 
 
Antigen Presentation Assay.
 
In experiments assessing the stim-
ulation of T cells by Percoll fractions, 10
 
8
 
 A20 IgM anti-DNP
cells were incubated for 30 min at 4
 
 
 
C with 10 
 
 
 
g/ml DNP-
coupled 
 
 
 
 repressor in RPMI 1640. The cells were washed and
incubated at a density of 2
 
  
 
 10
 
6
 
 cells per milliliter for 30 min or
3 h at 37
 
 
 
C in complete medium. Cells were fractionated as de-
scribed below and pools of the four fractions with 
 
  
 
hexosamini-
dase or APDE activity and containing equivalent amounts of pro-
tein, as determined by colorimetric assay, were transferred to
96-well plate DVPP Multiscreen membranes (Millipore) with a
96-well vacuum transfer apparatus (Bio-Rad Laboratories). T cell
stimulation was evaluated by adding 100 
 
 
 
l of a cell suspension
containing 2 
 
 
 
 10
 
4
 
 24.4 T cell hybridoma cells in complete me-
dium to each well. Plates were incubated for 18 h at 37
 
 
 
C, then
centrifuged for 10 min at 1,200 
 
g
 
. Supernatants were removed,
frozen at –80
 
 
 
C for 2 h, and IL-2 content was then determined
by CTLL-2 assay as described previously (15). Percoll fractions
from A20 cells, incubated with DNP-coupled OVA, did not
stimulate 24.4 T cells previously (data not shown), demonstrating
the specificity of 24.4 stimulation in experiments with 
 
 
 
 repressor
(see Fig. 1).
 
Western Blot Analysis.
 
Cells were lysed by incubation in lysis
buffer: 0.5% Triton, 300 mM NaCl, 50 mM Tris, pH 7.4, and 10
 
 
 
g/ml leupeptin, chemostatin, aprotinin, pepstatin, and 
 
N
 
-ethyl
maleimide. Cell lysates were diluted in reducing sample buffer
and boiled for 5 min before electrophoresis in 12% polyacryl-
amide gels containing SDS. Proteins were transferred to polyvi-
nylidene fluoride membranes (Millipore). The membranes were
incubated with blocking solution, followed by primary antibody
and then horseradish peroxidase–labeled species-specific anti-
body. Chemiluminescence was detected with a Boehringer kit.
For quantification of the p10 fragment of the invariant chain after
BcR stimulation, the membranes were probed with rabbit anti–
Ii-NH
 
2
 
 antibody, then with alkaline phosphase-coupled antise-
rum and binding was detected by incubation at room temperature
in a buffer containing AP substrate (Boehringer Mannheim). The
filters were sequentially probed with rabbit anti-IA 
 
 
 
 chain anti-
serum and an anti-tubulin mAb. Blots were visualized in a Storm
860 machine (Molecular Dynamics), and p10 signals were quanti-
fied (ImageQuant). Each lane was normalized on the basis of the
corresponding IA or tubulin signals. Similar results were obtained
with IA and tubulin normalization. 
 
Immunoelectron Microscopy.
 
Cells were fixed by incubation for
2 h at room temperature in a mixture of 2% paraformaldehyde in
0.2 M phosphate buffer, pH 7.4, (PB) and 0.125% glutaralde-
hyde. Fixed cells were processed for ultrathin cryosectioning and
immunogold labeling as described previously (5). In brief, cells
were washed with PB and 50 mM glycine in PB and were then
embedded in 7.5% gelatin. Small blocks were infiltrated with 2.3 M
sucrose at 4
 
 
 
C for 2 h and then frozen in liquid nitrogen. Ul-
trathin cryosections were cut with a Leica ultracut FCS (Vienna,
Austria) and retrieved in a mixture of 2% methylcellulose and
2.3 M sucrose (vol/vol). The sections were indirectly immu-
nogold-labeled with the rat mAb anti-I-A M5114, followed by a
rabbit anti–rat antibody (Dako) and various rabbit polyclonal an-
tisera. Bound antibodies were detected with protein A coupled to
10- and 15-nm gold particles (purchased from J.W. Slot, Utrecht
University, Utrecht, The Netherlands). The sections were con-
trast stained, embedded in a mixture of methylcellulose and ura-
nyl acetate and viewed with a CM120 Twin Phillips electron mi-
croscope (Eindhoven) (19). The distribution of MHC class II in
the various compartments of IIA1.6 cells and A20 cells before and
after stimulation was determined semiquantitatively on immu-
nogold-labeled ultrathin cryosections by counting the number of
gold particles labeling class II molecules in each of the defined
compartments in 30 randomly selected cell profiles. For electron
microscopy analysis, subcellular fractions were washed in PBS and
loaded on formvar-carbon coated grids by incubation for 20 min.
The fractions were immunogold-labeled with anti-class II anti-
bodies (polyclonal anti-IA directed against the cytoplasmic do-
main of class II) or with the M5114 mAb and protein A-gold par-
ticles (10 nm diameter). 
 
Immunofluorescence Staining and Confocal Microscopy.
 
Cells were
washed in PBS and collected on glass coverslips coated with poly-L
lysine (Sigma-Aldrich), to which they were allowed to adhere
for 30 min. Cells were then fixed in 3% paraformaldehyde for 10
min at room temperature and incubated with 100 mM glycine in
PBS. Cells were permeabilized by incubation in 0.05% saponin,
0.2% BSA in PBS, and incubated with the rat anti–H2-M mAb
(gift from L. Karlsonn). The cells were washed three times and
the binding of specific antibodies was detected using F(ab
 
 
 
)
 
2
 
 don-
key anti–rat or anti–rabbit antibodies conjugated to FITC or 
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Texas Red. The coverslips were then mounted in Mowiol. Con-
focal laser scanning microscopy was performed with a Leica TCS
microscope, consisting of a DM microscope interfaced with a
mixed gas argon/krypton laser (Leica Laser Technik) as described
previously (20).
 
Fluorometric Test for Cathepsin Activity.
 
IIA1.6 cells were pre-
pared as described above. Equal amounts of membranes (as deter-
mined by the Bradford test) in 1 M sodium acetate, 0.2 M
EDTA, 0.5 M DTT, 5% CHAPS (pH 5.5 or 7.0) were incubated
for 1 h at 37
 
 
 
C, in 96-well plates, with substrates of cathepsins:
200 mM Z-Val-Val-Arg-NHMec (a gift from P. Morton, USF,
Chesterfield, MO) for cathepsin S, in the presence or absence of
1 nM 
 
N
 
-morpholinurea–leucine–homophenylalanine vinylsul-
fone-phenyl (LHVS), and 80 mM Z-Phe-Arg-NHMec (Sigma-
Aldrich) for cathepsins B/L. Reactions were quantified at 
 
 
 
exc. 
 
 
 
355 nm and 
 
 
 
em. 
 
 
 
 460 nm, by fluorimetry (1420 VICTOR
 
2
 
™
multilabel counter; EG&G Wallac) (21). Same samples were
tested for 
 
 
 
 hexosaminidase activity, as described previously (17).
LHVS was provided by H. Ploegh (Harvard University, Bos-
ton, MA).
 
Labeling of the Active Site of Cysteine Proteases. 
 
We detected
active cysteine proteases with Mu–[
 
125
 
I]–Tyr–Ala–CH2F, as de-
scribed elsewhere (22). Cells (10
 
7
 
 cells per sample) were incu-
bated with or without the inhibitor LHVS (50 nM) at 37
 
 
 
C for
1 h before labeling and then with 50 nM Mu–[
 
125
 
I]–Tyr–Ala–
CH2F for 2 h at 37
 
 
 
C. Cells were washed twice with 1% FCS in
PBS and cell lysates were prepared as above. Cell lysates contain-
ing the same amount of radioactivity were boiled for 5 min and
then subjected to electrophoresis in a 12% acrylamide gel con-
taining SDS.
 
Results
 
The mouse B lymphoma cell lines A20 and IIA1.6 were
used for two major reasons: (i) they have the phenotype of
quiescent mature B cells expressing sIgG, or anti-DNP
IgM for A20 cells, and the intracellular machinery trigger-
ing BcR-mediated cell activation (15); and (ii) they consti-
tute a homogeneous population of B cells, ideal for func-
tional studies of antigen presentation and cell biological
analysis of MHC class II–containing compartments (6)
 
.
 
 We
aimed to analyze in detail the various cellular events occur-
ring during BcR-induced stimulation, focusing on changes
in the trafficking of MHC class II molecules and their part-
ners leading to efficient antigen presentation.
 
BcR Stimulation Induced the Redistribution of MHC Class II
into Dense Fractions of the Percoll Gradient.
 
We began by
analyzing the compartmentalization of MHC class II–
invariant chain complexes in IIA1.6 cells during BcR-
mediated B cell activation. Late endosomes and lysosomes
were purified by ultracentrifugation on a Percoll gradient.
 
 
 
 hexosaminidase activity and Lamp1 were detected in
heavy fractions corresponding to lysosomal and prelysoso-
mal compartments whereas APDE activity, rab5, rab7, and
Lamp1 were detected in light fractions corresponding to
the other cell membranes (Fig. 1 A). H2-M was detected
principally in the heavy fraction, but was also found in
other fractions. As previously described in these B lym-
phoma cells, MHC class II molecules were mostly present
in the light fraction (Fig. 1 A), which contained the plasma
membrane, ER, and Golgi apparatus, along with endo-
somes and CIIV (12). In contrast, 30 min after BcR cross-
linking with multivalent ligands, MHC class II and the p31
invariant chain were present not only in the light fraction,
but also in the heavy lysosome-containing fractions of the
Percoll gradient (Fig. 1 B), whereas no change in the intra-
cellular distributions of rab7, rab5, H2-M, and Lamp1 was
detected (data not shown). 
 
  
 
hexosaminidase-positive frac-
tions were pooled and their MHC class II and invariant
chain contents determined: these dense fractions contained
10–12% of total class II or entire invariant chain (Fig. 1 B).
A similar distribution of MHC class II was obtained with
A20 anti-DNP cells stimulated with soluble DNP-coupled
OVA (data not shown). Then we analyzed, by electron
microscopy, the morphology of the MIICs that sedimented
in the dense fractions of the Percoll gradient after the BcR
stimulation of IIA1.6 cells. The pooled dense fractions
consisted mostly of large vesicular structures (200–350 nm
diameter) with internal membrane sheets and vesicles (Fig.
1 C). Most of the isolated compartments were labeled with
an antiserum directed against the cytoplasmic domain of
the IA 
 
 
 
 chain (Fig. 1 C, top). In dense fractions, we also
observed small vesicular structures strongly labeled with
M5/114, which recognizes the luminal domain of the IA 
 
 
 
chain (Fig. 1 C, bottom). These vesicles probably corre-
spond to internal vesicles of the class II-positive MVBs dis-
rupted during washing, after fractionation. Thus, BcR
stimulation caused changes in the intracellular distributions
of MHC class II molecules and the invariant chain. We
then determined whether MHC class II–peptide com-
plexes were present in these MIICs after the internalization
of BcR-bound antigens. A20 cells expressing anti-DNP
IgM were incubated for various times with DNP-coupled
 
 
 
-repressor and then fractionated on a Percoll gradient.
Pools of dense fractions and of light fractions containing
similar amounts of protein were lysed in 96-well plates and
bound to nylon membrane. Presentation of the 
 
 
 
 repressor
was detected with the IAd-restricted T cell hybridoma:
24.4. T cell stimulation was detectable in the dense fraction
after 30 min, with weaker stimulation observed in the light
fraction (containing plasma membrane) at this time point
(Fig. 1 D), even though most of the MHC class II mole-
cules were found in light fractions (Fig. 1 B). After 3 h, T
cell stimulation increased in both fractions (Fig. 1 D).
MHC class II–peptide complexes were therefore generated
in MIICs that were redistributed to dense fractions during
BcR stimulation.
 
BcR Stimulation Induced p10 Accumulation and Downregu-
lated Cathepsin S Activity.
 
Although MHC class II–peptide
complexes were detected in heavy fractions of the Percoll
gradient, due to the high sensitivity of T cell hybridoma
most MHC class II molecules were associated with the in-
variant chain in lysosome-related compartments. Indeed,
immunoprecipitation of heavy fractions with the anti-class
II antibody, M5114, demonstrated that MHC class II
were associated with entire invariant chain or with a p10
degradation fragment 3 h after BcR engagement (data not
shown). Analysis of B cell lysates, at various times after 
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BcR stimulation, showed an increase in the amount of p10
invariant chain fragment detected with a rabbit antiserum
specific for the cytosolic domain of the invariant chain,
whereas MHC class II and 
 
 
 
 tubulin levels remained con-
stant (Fig. 2 A). The effect of BcR stimulation on invariant
chain degradation depended on the MHC class II allele; the
effect was strongest in IIA1.6 cells–expressing IA
 
 
 
. In pa-
rental IIA1.6 cells expressing IAd, p10 levels doubled (data
not shown), whereas they increased by a factor of 5 in IAk-
transfected IIA1.6 cells (Fig. 2 A) and in IIA1.6 cells ex-
pressing IAb (data not shown). However, the changes in
p10 levels over time were similar for both alleles: the p10
fragment was first detected after 30 min, increased to reach
a maximum at 3 h and then returned to its initial level after
6 h of BcR stimulation (Fig. 2 A). No change in de novo
MHC class II synthesis was observed in pulse-chase experi-
ments (data not shown). Although MHC class II–peptide
complexes were detected in dense fractions after BcR stim-
ulation, the increase in p10 invariant chain fragment levels
and the detection of invariant chain, together with MHC
class II, in late endosomal compartments after BcR cross-
linking suggests that the proteolytic degradation of invari-
ant chain was inhibited during B cell activation.
Therefore, we assessed various proteolytic activities dur-
ing BcR-induced cell activation. IIA1.6 cells were stimu-
lated for various times as described above, and the activities
of cathepsin S, cathepsin L/B, and 
 
 
 
 hexosaminidase were
assessed on the same membrane preparations by means of
fluorometric assays (23). Cathepsin S activity was measured
at pH 7.0 (Fig. 2 B) in membrane preparations of B cells
because cathepsin S is active at this pH, whereas cathepsin
B is not. We demonstrated that the activity measured cor-
responded to cathepsin S by adding low concentrations of
LHVS. Such low concentrations (1 nM) of LHVS inhibit
cathepsin S, but not cathepsin B. Higher concentrations of
LHVS (30 nM) are required to inhibit cathepsin B (24).
Cathepsin S activity decreased after BcR cross-linking:
maximal inhibition (75%) occurred at 3 h, with cathepsin S
activity progressively increasing thereafter and returning to
initial values after 6 h; 18 h after BcR cross-linking, 15%
inhibition of cathepsin activity was still observed. No
change in 
 
 
 
 hexosaminidase activity was detected in the
same samples, whereas cathepsin L/B activity decreased
slightly (Fig. 2 B). We directly measured cathepsin S activ-
ity in B cells by labeling stimulated and unstimulated
IIA1.6 cells with an iodinated peptide that bound specifi-
Figure 1. Redistribution of MHC class II–
invariant chain complexes to lysosomes after BcR
stimulation. (A) Percoll gradient fractionation of
IIA1.6 cells and A20 cells expressing anti-DNP
IgM. Cells were homogenized and the postnuclear
supernatant (PNS) was fractionated on a 22% Per-
coll gradient.   hexosaminidase activity and alka-
line phosphodiesterase activities were measured in
each fraction and protein content was determined
by Western blotting with anti-rab5, anti-rab7, anti-
Lamp1, anti-H2-M, and anti-IA  chain antibodies.
(B) Fractionation of MHC class II-containing com-
partments. Unstimulated and BcR-stimulated
IIA1.6 cells (cells were incubated for 30 min at
37 C with anti–mouse IgG antibodies) were frac-
tionated and   hexosaminidase and alkaline phos-
phodiesterase activities determined as in A. Pools of
light (black bars) or dense (white bars) fractions
were subjected to SDS-PAGE and MHC class II
and invariant chain were quantified as described in
Materials and Methods. The results shown are the
means of three experiments. (C) Immunogold la-
beling of dense fractions containing MHC class II
molecules after BCR stimulation. Membrane frac-
tions were processed, immunogold-labeled, and
contrast stained as described in Materials and Meth-
ods. (Top) The dense fractions are enriched in elec-
tron-dense compartments strongly labeled with an
antibody directed against the cytoplasmic domain
of IA. Internal membranes can be seen in the lu-
men of the electron-dense compartments. (Bottom)
In the electron-dense fractions, small vesicles, 60–
80 nm in diameter, are often observed. These vesi-
cles, labeled with the M5114 antibody, probably
correspond to the internal vesicles of multivesicular
class II compartments. Their presence in these frac-
tions is almost certainly due to the disruption of multivesicular bodies during fractionation. Scale bars, 100 nm. (D) DNP-coupled   repressor was bound
to A20 IgM anti-DNP cells at 4 C and the cells were incubated for 0 min, 30 min or 3 h at 37 C in complete medium. Cells were fractionated as below
and we analyzed 24.4 T cell stimulation for the pools of fractions with   hexosaminidase or APDE activity, but similar amounts of proteins, by determin-
ing the IL- 2 content of the supernatant with a CTLL-2 assay.  
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cally to the active site of cathepsin S (22). A 26-kD protein,
presumably cathepsin S, was specifically labeled in these
conditions and this labeling was inhibited in the presence of
LHVS peptide. This assay gave similar results to the original
assay, as 80% inhibition of cathepsin S labeling was ob-
served after 3 h and this inhibition was partially reversible
after 18 h (Fig. 2 C). No changes in the amounts of cathep-
sin S and cystatin C proteins present were detected by
Western blotting (data not shown). These results demon-
strate that BcR-induced B cell activation downregulated
cathepsin S activity, accounting for the transient accumula-
tion of MHC class II–invariant chain complexes in lyso-
somes. The changes in MIIC composition induced by B
cell activation suggest that BcR stimulation may trigger
morphological changes in processing compartments.
 
Redistribution of MHC Class II to Multivesicular Compart-
ments after BcR Stimulation.
 
We analyzed, after BcR stim-
ulation, changes in the intracellular compartmentalization
of IIA1.6 cells and A20 anti-DNP cells, by performing im-
munogold labeling with the rat monoclonal anti-class II an-
tibody, M5/114, on ultrathin cryosections of unstimulated
and BCR-stimulated cells. As previously described for un-
stimulated IIA1.6 and A20 cells, only a small proportion of
MHC class II molecules were detected within cells (12)
(and Fig. 3 A and E). Most of the intracellular class II mol-
ecules were present in small vesicles, and in tubulovesicular
structures beneath the plasma membrane (Fig. 3 A and E,
and Fig. 4 B). We identified these compartments, which
are probably related to CIIV (6), as endosomes because
they were labelled with anti–transferrin receptor antibody
Figure 2. BcR stimulation downregu-
lates cathepsin S activity in IIA1.6 cells. (A)
Accumulation of the p10 invariant chain
fragment in BcR-stimulated IIA1.6 cells.
IIA1.6 cells were incubated for the times in-
dicated with anti–mouse IgG antibodies, as
described in Materials and Methods. The
p10 fragment was detected with a rabbit
antiserum specific for the cytoplasmic tail
of the invariant chain. The same blot was
incubated with an anti-IA  chain antiserum
and then with an anti–  tubulin antibody
(left). In the right panel, the p10 signal is
normalized with the MHC class II signal
obtained for the same lane and these p10
signals are expressed in arbitrary units.
These results are representative of three in-
dependent experiments. (B) IIA1.6 cells
were left unstimulated or were stimulated for
various times with anti–mouse IgG antibod-
ies and membranes were prepared to assess
cathepsin S (top)   hexosaminidase (bottom
right), and cathepsin B/L (bottom left) ac-
tivities in fluorometric assays. Cathepsin S
activity was tested at pH 7.0, because ca-
thepsin S is functional at neutral pH, with
(white bars) or without (back bars) LHVS, a
cathepsin S inhibitor. Error bars correspond
to the mean of three experiments. (C) De-
tection of cathepsin S with an iodinated
peptide that binds to the active site of ca-
thepsin S. Stimulated or unstimulated cells
were incubated for 1 h with 125I-Mu-Tyr-
Ala-CH2F, with or without LHVS, and cell
lysates were then subjected to electrophore-
sis in 12% polyacrylamide gels. Cathepsin S
was detected as a 26-kD band. The labeling
of this protein was inhibited by adding
LHVS. LHVS did not inhibit the labeling of
an higher molecular weight band in the gel
at  32 kD, which was identified as cathepsin
L. Rat basophilic leukemia cell line cells,
which do not produce cathepsin S, were
used as a negative control. In the bottom
panel, each band was quantified with a
PhosphorImager™. Cathepsin S labeling was
normalized against labeling of the 32-kD
band for each lane and cathepsin S labeling
was quantified in arbitrary units. 
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but not with anti-Lamp1 antibody (12, 20). BcR stimula-
tion of IIA1.6 cells or A20 anti-DNP cells for 30 min to 3 h
radically changed the distribution of MHC class II mole-
cules and the morphology of the class II–containing com-
partments. First, the amount of intracellular class II mole-
cules increased considerably, by factor 3 in IIA1.6 cells after
3 h and by factor 6 in A20 cells after 30 min of IgM stimu-
lation (Fig. 4 A). Second, this intracellular pool of mole-
cules accumulated mainly in multivesicular MIICs, which
were rarely observed in unstimulated IIA1.6 and A20 cells.
All these modifications of MIICs were specifically related
to BcR engagement because the incubation of cells with
similar concentrations of irrelevant IgG complexes did not
modify the nature of compartments containing MHC class
II (data not shown). In these compartments, intense label-
ing for MHC class II was observed in the internal mem-
brane vesicles (Figs. 3 B, C, F, and 4 B). An important fea-
ture of MHC class II redistribution to multivesicular
compartments was the kinetics of this structural change in
the endocytic pathway. These changes occurred rapidly, as
they were detectable 10 min after BcR cross-linking (data
not shown). Class II molecules were still detected in multi-
vesicular compartments of IIA1.6 cells after 3 h (Fig. 3 C),
with increasing numbers of intracellular class II molecules
(Fig. 4 A and B) and an increasing number of compart-
ments. However, MHC class II accumulation in MVBs
seemed to be reversible because the number of intracellular
class II molecules in IIA1.6 cells had decreased by 18 h
(Fig. 4 A). As in unstimulated cells, most of the class II
molecules were present in numerous tubulovesicular mem-
brane structures distributed around the microtubule orga-
nizing center (data not shown) and beneath the plasma
Figure 3. Redistribution of
MHC class II molecules after
BcR stimulation. Ultrathin cry-
osections of unstimulated IIA.6
cells (A) and A20 IgM anti-DNP
cells (E) or IIA1.6 cells stimu-
lated for 30 min (B), 3 h (C), or
18 h (D), and A20 IgM anti-
DNP cells stimulated for 30 min
(F) were single immunogold-
labeled with the rat monoclonal
M5114 antibody and protein A
coupled to 10 nm gold particles
(PAG 10). (A) In unstimulated
cells, the majority of MHC class
II molecules were present on the
plasma membrane (PM) and in
small tubulovesicular structures
beneath the plasma membrane
(arrows). (B) After 30 min of
stimulation, MHC class II mole-
cules were detected on the
plasma membrane (PM), in small
tubular structures (arrows) and
in multivesicular bodies (stars).
(C) After 3 h, note the accumu-
lation of MHC class II molecules
in numerous multivesicular bod-
ies (stars). The plasma membrane
was also labeled (PM) (D) In cells
stimulated for 18 h, intracellular
MHC class II molecules were
present mostly in small vesicles
and tubules (arrows) and on the
plasma membrane (PM). (E) In
unstimulated A20 IgM anti-
DNP cells, MHC class II mole-
cules were detected at the plasma
membrane and in tubulovesicular
structures (arrows). (F) In A20
cells stimulated with DNP-OVA
for 30 min, MHC class II mole-
cules were visualized at the plasma
membrane and in multivesicular
bodies (star). Bars, 200 nm. 
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membrane (Figs. 3 D and 4 B). As expected (Figs. 1 and 2),
the invariant chain was mostly detected together with
MHC class II in the MVBs of BcR-stimulated IIA1.6 cells
(Fig. 5 A), whereas the invariant chain was present mostly
in the endoplasmic reticulum and Golgi apparatus before
stimulation (data not shown). Similar observations were
made for A20 anti-DNP cells (data not shown). These data
suggest that B cell activation may modify the intracellular
transport of MHC class II–invariant chain complexes, lead-
ing to the transient accumulation of these complexes in late
endosomes or prelysosomal compartments.
To determine the precise nature and position in the en-
docytic pathway of the BcR-induced MIICs, we labeled
ultrathin cryosections of stimulated-IIA1.6 cells. We clearly
identified these multivesicular compartments as a site of an-
tigen processing, based on the accumulation of multivalent
antigens and the BcR subunit, together with MHC class II
molecules recognized by the M5/114 antibody. Thus, 30
min after BcR stimulation with FITC-coupled F(ab
 
 
 
)
 
2
 
fragments of anti–mouse IgG antibodies, FITC was mostly
detected, with a specific anti-FITC antibody, in multive-
sicular class II compartments (Fig. 5 B). We also showed,
using a rabbit anti–Ig-
 
 
 
 antiserum, that Ig-
 
 
 
 subunits accu-
mulated in large amounts in the same compartments (Fig. 5
C). These data indicated that BcR-bound antigens entered
newly formed MVBs containing MHC class II molecules.
To determine the identity of these MVBs within the late
endocytic pathway, ultrathin cryosections of cells stimu-
lated for 30 min or 3 h were double immunogold-labeled
with anti-class II and anti-Lamp1 antibodies (Fig. 5 D) or
with anti-class II and anti-MPR antibodies (data not
shown). The class II-rich MVBs contained Lamp1 (Fig. 5
D). The lower intensity of labeling for MHC class II ob-
served in some of the double immunogold-labeling experi-
ments results from the use of a biotinylated-M5114 anti-
body to prevent artifactual colabeling with other mAbs.
These data demonstrate that BcR stimulation induced the
formation in mouse B cells of multivesicular MIICs with
the structural and biochemical features of the MIIC, previ-
ously described in human B cells. 
 
H2-M Redistribution in BcR-induced MIIC.
 
We further
investigated the composition of BcR-induced MIIC by an-
alyzing the distribution of molecules involved in antigen
presentation. First, we investigated the intracellular distri-
bution of nonpolymorphic H2-M during B cell activation
by BcR. Unstimulated and stimulated IIA1.6 cells were la-
beled with antibodies specific for H2-M and MHC class II
molecules. Bound antibodies were then detected with
FITC-coupled and Texas Red–coupled secondary anti-
bodies, respectively. The immunolabeling of H2-M and
MHC class II was analyzed by confocal microscopy. Before
activation, the bulk of MHC class II was located at the
plasma membrane, with only a minor fraction detected in
intracellular compartments (Fig. 6 A). In cells with faint in-
tracellular class II labeling, MHC class II molecules showed
only partial colocalization with H2-M, as some H2-M-
positive compartments were MHC class II-negative (Fig. 6
A). In a large proportion of cells, MHC class II molecules
Figure 4. Quantitative analysis of the distribu-
tion of MHC class II molecules during BCR stim-
ulation. (A) We counted the number of gold parti-
cles labeling intracellular class II molecules, under
the electron microscope, on 30 randomly selected
cell profiles. Note the increase in labeling of intra-
cellular class II molecules after 30 min and 3 h of
BcR stimulation and the slight decrease after 18 h.
(B) We counted the number of gold particles la-
beling MHC class II molecules in various intracel-
lular compartments (tubulovesicular structures,
preMVBs, MVBs, and lysosomes), under the elec-
tron microscope, on 30 cell profiles. Results are
presented as the percentage of gold particles in the
various compartments. 
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mostly accumulated at the plasma membrane whereas
H2-M was mostly found in intracellular compartments
previously identified as lysosomes in these cells (12). As ex-
pected from the data shown in Fig. 3, BcR engagement
rapidly induced the intracellular accumulation of MHC
class II in compartments labeled with specific anti–H2-M
antibodies (Fig. 6 A).
This suggests that BcR engagement modified the intra-
cellular distribution of H2-M, inducing their redistribution
from lysosomal compartments to newly formed MHC class
II multivesicular compartments. No modification of H2-M
expression was observed by Western blot analysis (data not
shown). We further investigated the nature of the H2-M–
containing compartments by immunogold labeling of ul-
trathin cryosections of stimulated and unstimulated IIA1.6
cells. In unstimulated cells, most H2-M was present in
compartments morphologically different from MVBs (Fig.
5 E). These compartments, which we classified as lyso-
somes based on their morphology and high Lamp1 content,
contained very few MHC class II molecules, and H2-M
molecules were occasionally detected in small vesicles at
the periphery of the cell (Fig. 5 F). BcR cross-linking had a
major effect on the distribution of H2-M. 30 min after the
start of B cell antigen stimulation, a large proportion of the
intracellular H2-M accumulated in multivesicular compart-
ments containing MHC class II (Figs. 5 F and 6 B). Thus,
Figure 5. Characterization of the multi-
vesicular compartments induced after BCR
stimulation. Ultrathin cryosections of
IIA1.6 cells stimulated for 30 min were
double immunogold-labeled with the rat
monoclonal M5.114 antibody and a poly-
clonal anti-invariant chain antibody (A), a
polyclonal anti-FITC antibody (B) or a rat
monoclonal anti-Lamp1 antibody (D). The
same cells were also single immunogold-
labeled with a rabbit polyclonal anti-Ig  an-
tibody (C). In D, a biotinylated M5.114 an-
tibody was used to avoid cross-reactions. In
E and F, ultrathin cryosections of unstimu-
lated IIA1.6 cells (E) or cells stimulated for
30 min (F) were double immunogold-labeled
with the M5.114 antibody (PAG 10)
and a biotinylated anti–H2-M antibody de-
tected with an anti-biotin antibody (PAG
15). (A) Note the presence of the invariant
chain (PAG 15) in the class II-rich multive-
sicular compartments (stars). (B) The FITC-
coupled Igs (PAG 15) clearly accumulate in
the class II molecule-containing multivesic-
ular compartments (PAG 10). (C) The mul-
tivesicular MIICs also contain Ig   (PAG
10) (star). (D) Both Lamp1 (PAG 15) and
MHC class II (PAG 10) are present in the
multivesicular MIICs. (E) In unstimulated
cells, most of the H2-M was present in
compartments containing internal electron-
dense membranes (Lys). (F) In cells stimu-
lated for 30 min, H2-M was detected in
characteristic class II molecule-containing
multivesicular compartments (star). Bars,
200 nm. 
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BcR simultaneously induced antigen targeting and the re-
distribution of H2-M to the MHC class II–containing
compartments.
Thus, our data show that BcR stimulation induced the
redistribution of MHC class II to newly formed multivesic-
ular compartments, together with antigen-bound BcR and
functional H2-M. In addition, the initial downregulation
of cathepsin S activity and the dynamic changes in MIICs
showed that BcR stimulation induced major changes in the
endocytic pathway that could account for the unique func-
tion of BcR in antigen presentation by B cells.
 
Discussion
 
In B cells, the endosomal and lysosomal compartments
are the intracellular sites of antigen degradation and peptide
loading onto MHC class II (3, 6). In this study, we demon-
strated that the binding of antigens to BcR profoundly
changed the distribution of MHC class II molecules in the
endocytic pathway of B cells. BcR cross-linking induced
the de novo formation of multivesicular compartments,
with morphological and biochemical features similar to
those of late endosomal MIICs, containing MHC class II,
H2-M, BcR, and antigens. Thus, BcR, which is known to
induce B cell activation and the uptake and targeting of an-
tigens to class II compartments, induced dynamic and re-
versible changes in the endocytic pathway, switching anti-
gen presentation on B cells on and off. 
How does BcR induce antigen presentation? BcR func-
tions similarly to many other cell surface receptors. The
binding of multivalent antigens to BcR results in the cross-
linking of the receptor and its recruitment to clathrin-
coated pits, increasing the uptake of BcR-bound antigens
(25). Thus, the primary function of BcR in antigen presen-
tation is facilitating the entry of antigens into the endocytic
pathway, in which proteases degrade proteins into peptides.
This proteolytic degradation of antigens is the first step in
antigen processing and is necessary but insufficient to in-
duce the efficient presentation of a large spectrum of pep-
tides. Thus, in addition to its quantitative effect on antigen
processing, BcR-mediated antigen uptake also induces the
presentation of a selective set of peptides (15). In contrast,
fluid-phase endocytosis of the same antigen induces the
presentation of only a few such peptides. Our data also
clearly show that BcR stimulation regulates the composi-
tion and nature of the endocytic compartments containing
MHC class II molecules.
Before antigen stimulation, class II molecules were
mainly present at the cell surface and in small tubulovesic-
ular structures likely to correspond to the previously de-
scribed CIIVs identified in the same B cell line (IIA1.6)
(6). Previous data have shown that BcR engagement may
modify MIICs in B cells. Several authors have reported
that CIIVs and MIICs may coexist in murine B cells after
BcR-mediated antigen uptake (26, 27). Other authors
have shown that BCR stimulation affects the nature of
MIICs (11). We showed in this study that BcR stimulation
induced the formation of compartments corresponding to
MVBs, containing internal membrane vesicles and Lamp1.
The newly formed MIICs have two features that are im-
portant for the antigen presentation functions of B cells.
First, they accumulate BCR-bound antigen, as shown pre-
viously (27). Second, these newly formed MIICs accumu-
late H2-M. H2-M play a key role in antigen presentation,
displacing the CLIP peptide or p10 fragment, as recently
proposed by H. Ploegh et al. (28), and enhancing the load-
ing of MHC class II with antigenic peptides (29). In con-
trast, the detection of invariant chain in these compart-
ments suggests that the regulation of invariant chain
degradation may be an original mechanism for inducing
Figure 6. BcR stimulation modifies H2-M intracellular localization. (A) Intracellular accumulation of H2-M and MHC class II after BcR stimulation.
IIA1.6 cells were not stimulated (top) or were stimulated (bottom) with anti–mouse IgG antibodies for 60 min. They were then fixed and processed for
immunofluorescence staining. Cells were labeled with the biotinylated anti-IAd antibody MKD6 and a rabbit anti–H2-M antiserum. Bound antibody
was detected with FITC-conjugated streptavidin and Texas Red–conjugated secondary antibodies, respectively. (B) Quantitative analysis of the distribu-
tion of H2-M during BCR stimulation was performed as in Fig. 4. Results are presented as the percentage of gold particles in the various compartments. 
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the accumulation of MHC class II and the formation of
MVBs after BcR stimulation, as the invariant chain is
known to retain MHC class II in the late endocytic path-
way (30).
How does BcR stimulation regulate invariant chain deg-
radation? The intracellular retention of MHC class II–
invariant chain complexes is potentially important because
it induces the concentration of MHC class II, together with
antigen-bound BcR, in processing compartments. The
downregulation of cathepsin S activity after BCR stimula-
tion may be essential for coordination of the transport of
MHC class II and BCR-bound antigen to the same pro-
cessing compartment. During the initial phase of B cell
stimulation, the downregulation of cathepsin S inhibited
the dissociation of invariant chain MHC class II complexes,
which were retained in lysosomal compartments. MHC
class II progressively concentrated together with BcR-
bound antigens in MIIC. Cathepsin S activity later re-
turned to basal levels, Ii was degraded, mature MHC class
II molecules were transported to the cell surface, and the
newly formed MIICs disappeared. Two lines of evidence
support this model. First, higher levels of transient intracel-
lular accumulation of MHC class II and p10 fragment were
observed in IIA1.6 cells expressing class II alleles with a
strong affinity for invariant chain such IAk (Fig. 2 A and
data not shown). Second, no modification of class II com-
partments was observed in transgenic anti-hen egg lyso-
zyme/Ii deficient mice after BcR engagement (31). In ad-
dition, we observed that MIIC formation and cathepsin S
downregulation occurred simultaneously after BcR stimu-
lation. Such modifications to the endocytic pathway and
MHC class II maturation and transport have previously
been observed during DC maturation (8). In immature
DCs, MHC class II molecules are found with the invariant
chain and H2-M in lysosomal MIICs (7). Upon inflamma-
tory stimuli, such as LPS, the DCs mature and MHC class
II, devoid of invariant chain is detected in CIIVs. The pres-
ence of invariant chain in class II compartments is related to
cathepsin S activity (22). Cathepsin S activity is inhibited
by cystatin C in immature DCs and maturation signals,
such as LPS, downregulate cystatin C production, leading
to an increase in cathepsin S activity and degradation of the
invariant chain (8). In addition, there is a clear relationship
between maturation status and the ability of DCs to process
exogenous antigens. Immature DCs are very efficient at
capturing antigens and processing them to give peptides
that associate with MHC class II in MIIC-related compart-
ments. In contrast, mature DCs express higher levels of
MHC class II at the cell surface but inefficiently capture
and process antigens. Therefore, the cell biology of antigen
presentation seems to be very similar in B cells and DCs. In
both cases, efficient antigen processing is associated with
the accumulation of MHC class II–invariant chain together
with H2-M and antigens in MIIC-related compartments
and with the downregulation of cathepsin S activity, with
no change in cystatin C production during BcR-mediated
B cell activation (data not shown). Another difference from
DCs is the expression of a clonotypic receptor, which ini-
tiates, in antigen-specific B cells, both cell activation and
antigen processing. 
This major feature of B cells raises a new question: how
does BcR coordinate antigen transport and MHC class II
redistribution in the endocytic pathway? Two lines of evi-
dence suggest that the coordination of these two processes
is important in BcR-induced antigen presentation. First,
we found that BcR stimulation induced the redistribution
of H2-M, with MHC class II, to the same multivesicular
compartments as BCR-bound antigens. Second, BcR-medi-
ated antigen presentation in A20 cells, the downregulation
of cathepsin S activity and MIIC formation showed similar
kinetics. MHC class II–peptide complexes were detected in
newly formed MVBs after 30 min (Fig. 1 D), probably due
to the loading of empty MHC class II in endosomes. How-
ever, we previously reported that cell surface antigen pre-
sentation began 2–3 h after the binding of antigen to BcR,
and reached a maximum after 6–18 h (15, 20) (data not
shown), when cathepsin S activity returned to basal levels.
Therefore, there is a lag time of a few hours between the
entry of antigens into B cells and the expression at the cell
surface of MHC class II–peptide complexes. This corre-
sponds to the time required for MIIC formation (30 min–3 h),
and the disappearance of these compartments that we ob-
served 18 h after BCR stimulation. 
In the current working model for antigen targeting,
BcR captures antigens at the surface of B cells, targeting
BcR-bound antigen to early endosomes. In these compart-
ments, the receptors are sorted towards preexisting late
compartments of the endocytic pathway, which contain
MHC class II molecules. BcR cross-linking is thought to
induce the concomitant recruitment of cytosolic effectors,
which turn on B cell activation, leading to dramatic
changes in the form and functions of B cells. Recent data
have suggested that the signaling and targeting functions of
BcR are related (10, 15). An alternative model may be thus
put forward. During the transport of BcR in the endocytic
pathway, the recruitment of cytosolic effectors by BcR
may modify the composition of BcR-linked endosomal
compartments. The direct consequences of BcR-induced
B cell activation would therefore include modification of
the nature and content of endo/lysosomal compartments
and induction of the formation of multivesicular bodies
containing MHC class II. Identification of the cytosolic ef-
fectors responsible for MVB formation will make it possi-
ble to validate this model and to extend our understanding
of the intracellular mechanisms underlying the dynamic
changes in the endocytic pathway that turn on antigen pre-
sentation by B cells.
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